Joseph J. Ciaffoni
Net Worth
Last updated:
What is Joseph J. Ciaffoni net worth?
The estimated net worth of Mr. Joseph J. Ciaffoni is at least $35,018,945 as of 21 Dec 2023. He owns shares worth $10,276,750 as insider, has earned $16,832,195 from insider trading and has received compensation worth at least $7,910,000 in Collegium Pharmaceutical, Inc..
What is the salary of Joseph J. Ciaffoni?
Mr. Joseph J. Ciaffoni salary is $1,130,000 per year as Pres, Chief Executive Officer & Director in Collegium Pharmaceutical, Inc..
How old is Joseph J. Ciaffoni?
Mr. Joseph J. Ciaffoni is 54 years old, born in 1971.
What stocks does Joseph J. Ciaffoni currently own?
As insider, Mr. Joseph J. Ciaffoni owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Collegium Pharmaceutical, Inc. (COLL) | Pres, Chief Executive Officer & Director | 275,000 | $37.37 | $10,276,750 |
What does Collegium Pharmaceutical, Inc. do?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Joseph J. Ciaffoni insider trading
Collegium Pharmaceutical, Inc.
Mr. Joseph J. Ciaffoni has made 36 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 4,357 units of COLL stock worth $132,379 on 21 Dec 2023.
The largest trade he's ever made was exercising 76,653 units of COLL stock on 1 Dec 2022. As of 21 Dec 2023 he still owns at least 275,000 units of COLL stock.
Collegium Pharmaceutical key executives
Collegium Pharmaceutical, Inc. executives and other stock owners filed with the SEC:
- Dr. Richard Malamut (65) Executive Vice President & Chief Medical Officer
- Mr. Joseph J. Ciaffoni (54) Pres, Chief Executive Officer & Director
- Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. (61) Co-Founder & Chairman
- Ms. Shirley R. Kuhlmann (41) Executive Vice President, Gen. Counsel & Sec.